Dosage Forms

Articles

The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.

Reig Jofre and Leanbio Form Joint Venture to Develop Biosimilars

The active pharmaceutical ingredient and excipient provider has expanded its parenteral ingredient manufacturing capacity and lab services.

BioSpectra Expands Manufacturing Capacity and Lab Services

Revisions to chapters on glass containers and elastomeric closures were canceled following review of comments.

USP Cancels Revisions to Packaging Chapters

Under this agreement, the companies will develop in parallel an antibody drug candidate and cell lines for other potential candidates.

ProBioGen and Surface Oncology Sign Second Antibody Manufacturing Program

The company is voluntarily recalling three lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial and one lot of Labetalol Hydrochloride Injection, USP, Novaplus because of the potential of cracked glass at the rim of the vials.

Hospira Recalls Labetalol Hydrochloride Due to Cracked Vials

FDA Commissioner Gottlieb expects that the saline and amino acid drug shortages from Puerto Rican manufacturing facilities will improve in the early part of 2018.

FDA Commissioner Gottlieb Gives Update on Saline and Amino Acid Shortages

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

The development of new packaging solutions that are fit for drugs of the future requires close collaboration between the pharmaceutical manufacturer and its packaging suppliers and machine vendors.

Elucidating Parenteral Packaging Requirements for Future Drugs

Measurements by a drone-based online pressure monitoring system help identify weak points in the filling line, enabling the process to be optimized. 

In-Line Force Analysis During Vial Filling

Glass and plastic are well established primary packaging materials for the pharmaceutical industry but they both have their advantages and disadvantages. 

Glass or Plastic—A Question of Use

The recall was initiated due to a product complaint in which white particulate matter, identified as mold, was discovered in a flexible bag from one batch.

Parenterals and Injectables